Ronald Wooten

Prof. Ronald Wooten

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2010 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
RBRachel Balder
Rachel Balder
SLSerena Lipski
Serena Lipski
JLJohn J Lazarus
John J Lazarus
WGWilliam Grose
William Grose
RWRonald Wooten
Ronald Wooten
ELEric R Lafontaine
Eric R Lafontaine
Background: Burkholderia pseudomalleiandBurkholderia malleicause the diseases melioidosis and glanders, respectively. A well-studied aspect of pathogenesis by these closely-related bacteria is their ability to invade and multiply within eukaryotic cells. In contrast, the means by whichB. pseudomalleiandB. malleiadhere to cells are poorly defined. The purpose of this study was to identify adherence factors expressed by these organisms.Results: Comparative sequence analyses identified a gene product in the published genome ofB. malleistrain ATCC23344 (locus # BMAA0649) that resembles the well-characterizedYersinia enterocoliticaautotransporter adhesin YadA. The gene encoding thisB. malleiprotein, designatedboaA, was expressed inEscherichia coliand shown to significantly increase adherence to human epithelial cell lines, specifically HEp2 (laryngeal cells) and A549 (type II pneumocytes), as well as to cultures of normal human bronchial epithelium (NHBE). Consistent with these findings, disruption of theboaAgene inB. malleiATCC23344 reduced adherence to all three cell types by ~50%. The genomes of theB. pseudomalleistrains K96243 and DD503 were also found to containboaAand inactivation of the gene in DD503 considerably decreased binding to monolayers of HEp2 and A549 cells and to NHBE cultures.A second YadA-like gene product highly similar to BoaA (65% identity) was identified in the published genomic sequence ofB. pseudomalleistrain K96243 (locus # BPSL1705). The gene specifying this protein, termedboaB, appears to beB. pseudomallei-specific. Quantitative attachment assays demonstrated that recombinantE. coliexpressing BoaB displayed greater binding to A549 pneumocytes, HEp2 cells and NHBE cultures. Moreover, aboaBmutant ofB. pseudomalleiDD503 showed decreased adherence to these respiratory cells. Additionally, aB. pseudomalleistrain lacking expression of bothboaAandboaBwas impaired in its ability to thrive inside J774A.1 murine macrophages, suggesting a possible role for these proteins in survival within professional phagocytic cells.Conclusions: TheboaAandboaBgenes specify adhesins that mediate adherence to epithelial cells of the human respiratory tract. TheboaAgene product is shared byB. pseudomalleiandB. malleiwhereas BoaB appears to be aB. pseudomallei-specific adherence factor.

19 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YCYutein Chung
Yutein Chung
NZNan Zhang
Nan Zhang
RWRonald Wooten
Ronald Wooten
Borrelia burgdorferi (Bb) is a tick-borne spirochete that is the causative agent for Lyme disease. Our previous studies indicate that virulent Bb can potently enhance IL-10 production by macrophages (MØs) and that blocking IL-10 production significantly enhances bacterial clearance. We hypothesize that skin-associated APC types, such as MØs and dendritic cells (DCs) are potent producers of IL-10 in response to Bb, which may act in autocrine fashion to suppress APC responses critical for efficient Bb clearance. Our goal is to delineate which APC immune functions are dysregulated by Bb-elicited IL-10 using a murine model of Lyme disease. Our in vitro studies indicated that both APCs rapidly produce IL-10 upon exposure to Bb, that these levels inversely correlate with the production of many Lyme-relevant proinflammatory cytokines and chemokines, and that APCs derived from IL-10-/- mice produced greater amounts of these proinflammatory mediators than wild-type APCs. Phagocytosis assays determined that Bb-elicited IL-10 levels can diminish Bb uptake and trafficking by MØs, suppresses ROS production, but does not affect NO production; Bb-elicited IL-10 had little effect on phagocytosis, ROS, and NO production by DCs. In general, Bb exposure caused little-to-no upregulation of several critical surface co-stimulatory markers by MØs and DCs, however eliminating Bb-elicited IL-10 allowed a significant upregulation in many of these co-stimulatory receptors. These data indicate that IL-10 elicited from Bb-stimulated MØs and DCs results in decreased production of proinflammatory mediators and co-stimulatory molecules, and suppress phagocytosis-associated events that are important for mediating both innate and adaptive immune responses by APCs.

14 December 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MWMichael E Woodman
Michael E Woodman
RWRandall G Worth
Randall G Worth
RWRonald Wooten
Ronald Wooten
Burkholderia pseudomallei is the causative agent of melioidosis and is a major mediator of sepsis in its endemic areas. Because of the low LD50 via aerosols and resistance to multiple antibiotics, it is considered a Tier 1 select agent by the CDC and APHIS. B. pseudomallei is an encapsulated bacterium that can infect, multiply, and persist within a variety of host cell types. In vivo studies suggest that macrophages and neutrophils are important for controlling B. pseudomallei infections, however few details are known regarding how neutrophils respond to these bacteria. Our goal is to describe the capacity of human neutrophils to control highly virulent B. pseudomallei compared to the relatively avirulent, acapsular B. thailandensis using in vitro analyses. B. thailandensis was more readily phagocytosed than B. pseudomallei, but both displayed similar rates of persistence within neutrophils, indicating they possess similar inherent abilities to escape neutrophil clearance. Serum opsonization studies showed that both were resistant to direct killing by complement, although B. thailandensis acquired significantly more C3 on its surface than B. pseudomallei, whose polysaccharide capsule significantly decreased the levels of complement deposition on the bacterial surface. Both Burkholderia species showed significantly enhanced uptake and killing by neutrophils after critical levels of C3 were deposited. Serum-opsonized Burkholderia induced a significant respiratory burst by neutrophils compared to unopsonized bacteria, and neutrophil killing was prevented by inhibiting NADPH-oxidase. In summary, neutrophils can efficiently kill B. pseudomallei and B. thailandensis that possess a critical threshold of complement deposition, and the relative differences in their ability to resist surface opsonization may contribute to the distinct virulence phenotypes observed in vivo.

1 March 2008 in Infection and Immunity
Verified
Journal Article
Closed access
JLJohn J. Lazarus
John J. Lazarus
MKMaria A. Kay
Maria A. Kay
AMAkisha L. McCarter
Akisha L. McCarter
RWRonald Wooten
Ronald Wooten
Although it is capable of eliciting strong innate and adaptive immune responses,Borrelia burgdorferioften evades immune clearance through largely unknown mechanisms. Our previous studies determined that infected interlukin-10−/−(IL-10−/−) mice show significantly lowerB. burgdorferilevels than wild-type (B6) mice and that IL-10 inhibits innate immune responses critical for controllingB. burgdorferiinfection. To determine whether virulentB. burgdorferipreferentially enhances IL-10 production, we developed an in vitro coculture medium (RPMI.B) in which bothB. burgdorferiand primary macrophages (Mφs) remain viable.B. burgdorferigrew at similar rates and was able to regulate expression of immunoreactive proteins with similar kinetics in RPMI.B and in traditional BSK medium; in contrast,B. burgdorfericultured in conventional tissue culture medium (RPMI) rapidly lost viability. Coculture of viableB. burgdorferiin RPMI.B with Mφs resulted in more rapid and significant increases in IL-10 transcripts and secreted proteins than coculture with nonviableB. burgdorferiin RPMI, which corresponded with decreased production of proinflammatory cytokines. Addition of liveB. burgdorferito Mφs in RPMI.B also elicited substantially higher IL-10 levels than heat-killed bacteria elicited, confirming that increased IL-10 production was not inherent to coculture in RPMI.B. Transfer of supernatants fromB. burgdorferi-stimulated Mφs into naïve Mφ cultures resulted in suppressed activation upon subsequent stimulation with different bacterial agonists, and this suppression was obviated by IL-10-specific antibody. In vivo analyses determined that murine skin samples exhibited substantial upregulation of IL-10 within 24 h of injection ofB. burgdorferi. Together, these results suggest that viableB. burgdorferican suppress early Mφ responses during infection by causing increased release of IL-10.

21 August 2014 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
MMMinal Mulye
Minal Mulye
MBMichael P. Bechill
Michael P. Bechill
WGWilliam Grose
William Grose
VFViviana P. Ferreira
Viviana P. Ferreira
ELEric R. Lafontaine
Eric R. Lafontaine
RWRonald Wooten
Ronald Wooten
Infection of susceptible hosts by the encapsulated Gram-negative bacterium Burkholderia pseudomallei (Bp) causes melioidosis, with septic patients attaining mortality rates ≥40%. Due to its high infectivity through inhalation and limited effective therapies, Bp is considered a potential bioweapon. Thus, there is great interest in identifying immune effectors that effectively kill Bp. Our goal is to compare the relative abilities of murine macrophages and neutrophils to clear Bp, as well as determine the importance of serum opsonins and bacterial capsule. Our findings indicate that murine macrophages and neutrophils are inherently unable to clear either unopsonized Bp or the relatively-avirulent acapsular bacterium B. thailandensis (Bt). Opsonization of Bp and Bt with complement or pathogen-specific antibodies increases macrophage-uptake, but does not promote clearance, although antibody-binding enhances complement deposition. In contrast, complement opsonization of Bp and Bt causes enhanced uptake and killing by neutrophils, which is linked with rapid ROS induction against bacteria exhibiting a threshold level of complement deposition. Addition of bacteria-specific antibodies enhances complement deposition, but antibody-binding alone cannot elicit neutrophil clearance. Bp capsule provides some resistance to complement deposition, but is not anti-phagocytic or protective against reactive oxygen species (ROS)-killing. Macrophages were observed to efficiently clear Bp only after pre-activation with IFNγ, which is independent of serum- and/or antibody-opsonization. These studies indicate that antibody-enhanced complement activation is sufficient for neutrophil-clearance of Bp, whereas macrophages are ineffective at clearing serum-opsonized Bp unless pre-activated with IFNγ. This suggests that effective immune therapies would need to elicit both antibodies and Th1-adaptive responses for successful prevention/eradication of melioidosis. Burkholderia pseudomallei is the causative agent of melioidosis, which is a major cause of septic death in endemic areas of Southeast Asia and northern Australia. This range now appears to be expanding, and with the increased incidence of diabetes, which is a major predisposing factor for B. pseudomallei infections, it is believed these cases will continue to increase. This organism is also categorized as a Tier 1 select agent with great potential for misuse as a bioweapon. Thus, there is great interest in developing vaccines and other immunotherapies for melioidosis. To better design these treatments, it is essential to understand which immune cells are capable of controlling B. pseudomallei, particularly during early stages of infection, and which immune mediators are required for these cells to optimally eradicate these bacteria. In this work, we identified that both macrophages and neutrophils were capable of internalizing and killing B. pseudomallei, but required different immune mediators to allow these effects. Complement and antibody-mediated opsonization was sufficient to promote uptake and killing of B. pseudomallei by neutrophils, whereas these opsonins could only enhance uptake by macrophages; macrophage-mediated killing required IFNγ. These findings suggest that successful therapies must elicit complement-activating antibodies and IFNγ to eradicate/prevent melioidosis.

Verified
Journal Article
Open access
PDF file
RSRobin Su
Robin Su
JBJoshua Breidenbach
Joshua Breidenbach
KAKhaled Alganem
Khaled Alganem
FKFatimah Khalaf
Fatimah Khalaf
BFBenjamin French
Benjamin French
SHSteven Haller
Steven Haller
We were the first to previously report that microcystin-LR (MC-LR) has limited effects within the colons of healthy mice but has toxic effects within colons of mice with pre-existing inflammatory bowel disease. In the current investigation, we aimed to elucidate the mechanism by which MC-LR exacerbates colitis and to identify effective therapeutic targets. Through our current investigation, we report that there is a significantly greater recruitment of macrophages into colonic tissue with pre-existing colitis in the presence of MC-LR than in the absence of MC-LR. This is seen quantitatively through IHC staining and the enumeration of F4/80-positive macrophages and through gene expression analysis for Cd68, Cd11b, and Cd163. Exposure of isolated macrophages to MC-LR was found to directly upregulate macrophage activation markers Tnf and Il1b. Through a high-throughput, unbiased kinase activity profiling strategy, MC-LR-induced phosphorylation events were compared with potential inhibitors, and doramapimod was found to effectively prevent MC-LR-induced inflammatory responses in macrophages.